14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
WBD vs VTRS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Viatris Inc. (VTRS) is the stronger overall head-to-head candidate over Warner Bros. Discovery, Inc. Series A (WBD) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). WBD carries a Unified Composite Score of 44.2/100 (HOLD) at $30.95 (N/M Forward P/E, 5.1% operating margin), whereas VTRS carries 52.2/100 (HOLD) at $19.63 (7.1x Forward P/E, 11.5% operating margin).
Competes within the Drug Manufacturers - Specialty & Generic value chain with $22.8B market capitalization and 11.5% operating margin.
OpEx & R&D Reinvestment29.6% of Rev ($4.36B)
90D Engineering Disclosures0 Published
Investor FAQ WBD vs VTRS Key Questions & Quantitative Answers
As of Nov 20, 2026, Viatris Inc. (VTRS) is the stronger overall head-to-head candidate over Warner Bros. Discovery, Inc. Series A (WBD) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). WBD carries a Unified Composite Score of 44.2/100 (HOLD) at $30.95 (N/M Forward P/E, 5.1% operating margin), whereas VTRS carries 52.2/100 (HOLD) at $19.63 (7.1x Forward P/E, 11.5% operating margin). Technically, WBD sits in a Markup phase (RSI 75.1, UNCLASSIFIED options structure) and VTRS sits in a Markup phase (RSI 52.3, BREAKOUT options structure).
VTRS leads the Growth & Scale pillar: WBD posts -11.2% YoY revenue growth and -90.6% YoY earnings growth on $36.1B TTM revenue (47.8% gross margin, 5.1% operating margin), compared with VTRS at -0.3% YoY revenue growth and -70.6% YoY earnings growth on $14.7B TTM revenue (41.1% gross margin, 11.5% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), WBD cumulative revenue shifted +253.6% while VTRS shifted +26.4%. In operating R&D and SG&A reinvestment, WBD deploys 42.7% of Rev ($15.4B) (0 90-day corporate R&D disclosures) versus 29.6% of Rev ($4.36B) (0 disclosures) for VTRS.
VTRS screens cheaper on headline valuation multiples. WBD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 2.9x EV/Revenue (6.0% FCF margin), whereas VTRS trades at 7.1x Forward P/E, 7.4x Trailing P/E, 3.69x PEG, and 2.3x EV/Revenue (13.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WBD (-8.8% ROE) versus VTRS (-4.2% ROE) capital efficiency.
In options market volatility and institutional positioning, WBD carries 1.3% implied volatility (1st %ile, Compressed (<25th %ile)), a 1.33x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.47β · 39% Vol realized risk). By comparison, VTRS carries 31.9% implied volatility (42nd %ile, Balanced (25th–60th %ile)), a 0.24x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKOUT options structure phase (0.55β · 31% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.